Exagen (XGN) News Today $3.58 -0.20 (-5.29%) Closing price 04:00 PM EasternExtended Trading$3.75 +0.17 (+4.78%) As of 05:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Exagen Inc. (NASDAQ:XGN) Short Interest Up 260.8% in JanuaryExagen Inc. (NASDAQ:XGN - Get Free Report) was the target of a large growth in short interest in January. As of January 31st, there was short interest totalling 26,700 shares, a growth of 260.8% from the January 15th total of 7,400 shares. Based on an average daily volume of 170,600 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.3% of the company's stock are sold short.February 12, 2025 | marketbeat.comExagen Inc. to Participate in Upcoming Investor ConferencesFebruary 4, 2025 | globenewswire.comRevealed Tomorrow: The Stocks Poised for Big Gains in FebruaryFebruary 2, 2025 | msn.comExagen Inc. (NASDAQ:XGN) Short Interest Down 90.7% in JanuaryExagen Inc. (NASDAQ:XGN - Get Free Report) saw a significant drop in short interest in the month of January. As of January 15th, there was short interest totalling 7,400 shares, a drop of 90.7% from the December 31st total of 79,200 shares. Based on an average daily volume of 140,000 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.1% of the shares of the company are sold short.January 30, 2025 | marketbeat.comFY2024 EPS Estimates for Exagen Lowered by Cantor FitzgeraldExagen Inc. (NASDAQ:XGN - Free Report) - Analysts at Cantor Fitzgerald reduced their FY2024 earnings estimates for shares of Exagen in a research report issued to clients and investors on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn now expects that the company will post earnings peJanuary 23, 2025 | marketbeat.comExagen Gains 28%, Insider Trades Reap BenefitJanuary 20, 2025 | finance.yahoo.comExagen (NASDAQ:XGN) Given "Overweight" Rating at Cantor FitzgeraldCantor Fitzgerald restated an "overweight" rating and set a $8.00 price target on shares of Exagen in a report on Monday.January 13, 2025 | marketbeat.comExagen Gets Conditional Approval For New Lupus And RA Biomarker Assays In New YorkJanuary 13, 2025 | markets.businessinsider.comExagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis ...January 12, 2025 | gurufocus.comExagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis ...January 12, 2025 | gurufocus.comExagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial ResultsJanuary 12, 2025 | globenewswire.comExagen price target raised to $7 from $5 at CanaccordJanuary 4, 2025 | markets.businessinsider.comCanaccord Genuity Group Forecasts Strong Price Appreciation for Exagen (NASDAQ:XGN) StockCanaccord Genuity Group increased their target price on shares of Exagen from $5.00 to $7.00 and gave the stock a "buy" rating in a report on Friday.January 3, 2025 | marketbeat.comExagen Inc. (NASDAQ:XGN) Short Interest Up 36.5% in DecemberExagen Inc. (NASDAQ:XGN - Get Free Report) saw a significant growth in short interest in December. As of December 15th, there was short interest totalling 78,100 shares, a growth of 36.5% from the November 30th total of 57,200 shares. Approximately 0.9% of the shares of the stock are short sold. Based on an average daily volume of 82,200 shares, the short-interest ratio is currently 1.0 days.December 28, 2024 | marketbeat.comExagen (NASDAQ:XGN) Trading 1.4% Higher - Still a Buy?Exagen (NASDAQ:XGN) Stock Price Up 1.4% - Time to Buy?December 25, 2024 | marketbeat.comExagen achieves key milestone with 1M patient tested by AVISE CTDDecember 13, 2024 | markets.businessinsider.comExagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTDDecember 12, 2024 | globenewswire.comExagen Inc. (NASDAQ:XGN) Shares Sold by Wasatch Advisors LPWasatch Advisors LP lowered its stake in Exagen Inc. (NASDAQ:XGN - Free Report) by 35.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 490,205 shares of the company's stock after selling 272,054 shares during theDecember 2, 2024 | marketbeat.comInsider Selling: Exagen Inc. (NASDAQ:XGN) Major Shareholder Sells 200,000 Shares of StockNovember 28, 2024 | insidertrades.comJohn Aballi Buys 24,305 Shares of Exagen Inc. (NASDAQ:XGN) StockNovember 19, 2024 | insidertrades.comCantor Fitzgerald Increases Earnings Estimates for ExagenExagen Inc. (NASDAQ:XGN - Free Report) - Equities researchers at Cantor Fitzgerald raised their FY2024 earnings estimates for shares of Exagen in a research report issued to clients and investors on Wednesday, November 13th. Cantor Fitzgerald analyst R. Osborn now anticipates that the company wilNovember 18, 2024 | marketbeat.comWhat is William Blair's Forecast for Exagen FY2024 Earnings?Exagen Inc. (NASDAQ:XGN - Free Report) - Equities researchers at William Blair boosted their FY2024 earnings per share (EPS) estimates for Exagen in a report issued on Wednesday, November 13th. William Blair analyst A. Brackmann now forecasts that the company will post earnings per share of ($0.8November 18, 2024 | marketbeat.comExagen Inc (XGN) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Growth ...November 14, 2024 | finance.yahoo.comExagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD PlatformNovember 14, 2024 | globenewswire.comQ3 2024 Exagen Inc Earnings CallNovember 13, 2024 | uk.finance.yahoo.comExagen’s Strategic Advancements and Market Potential Drive Buy Rating Amidst Upcoming ADVISE Test LaunchNovember 13, 2024 | markets.businessinsider.comExagen Inc. (NASDAQ:XGN) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | msn.comExagen (NASDAQ:XGN) Receives "Outperform" Rating from William BlairWilliam Blair restated an "outperform" rating on shares of Exagen in a research report on Wednesday.November 13, 2024 | marketbeat.comExagen Inc. Reports Third Quarter 2024 ResultsNovember 13, 2024 | markets.businessinsider.comExagen Inc. Reports Q3 2024 Financial ResultsNovember 13, 2024 | markets.businessinsider.comExagen Inc (XGN) Q3 2024 Earnings Report Preview: What To ExpectNovember 11, 2024 | finance.yahoo.comExagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology ConvergenceOctober 21, 2024 | globenewswire.comShort Interest in Exagen Inc. (NASDAQ:XGN) Expands By 20.9%Exagen Inc. (NASDAQ:XGN - Get Free Report) was the recipient of a large increase in short interest in September. As of September 15th, there was short interest totalling 16,800 shares, an increase of 20.9% from the August 31st total of 13,900 shares. Approximately 0.2% of the company's stock are sold short. Based on an average daily trading volume, of 54,600 shares, the short-interest ratio is currently 0.3 days.September 28, 2024 | marketbeat.comOctopus buys British solar and battery storage firm ExagenSeptember 24, 2024 | msn.comShareholders in Exagen (NASDAQ:XGN) have lost 84%, as stock drops 12% this past weekSeptember 13, 2024 | finance.yahoo.comExagen Inc. to Participate in the 2024 Cantor Global Healthcare ConferenceSeptember 4, 2024 | globenewswire.comShort Interest in Exagen Inc. (NASDAQ:XGN) Decreases By 41.5%Exagen Inc. (NASDAQ:XGN - Get Free Report) saw a large decrease in short interest during the month of August. As of August 15th, there was short interest totalling 15,800 shares, a decrease of 41.5% from the July 31st total of 27,000 shares. Approximately 0.2% of the company's stock are short sold. Based on an average daily trading volume, of 51,200 shares, the days-to-cover ratio is currently 0.3 days.August 28, 2024 | marketbeat.comExagen GAAP EPS of $0.16 beats by $0.50, revenue of $15.1M beats by $1.97MAugust 6, 2024 | msn.comExagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record PerformanceAugust 6, 2024 | markets.businessinsider.comExagen, Inc. (XGN) Q2 2024 Earnings Call TranscriptAugust 6, 2024 | seekingalpha.comExagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth ConferenceAugust 2, 2024 | globenewswire.comExagen Appoints Jeffrey G. Black as New Chief Financial OfficerAugust 1, 2024 | globenewswire.comExagen to Announce Second Quarter 2024 Results on August 5, 2024July 22, 2024 | globenewswire.comExagen Inc. (XGN)May 19, 2024 | finance.yahoo.comInsider Buying: Exagen Inc. (NASDAQ:XGN) CEO Buys 40,401 Shares of StockMay 17, 2024 | insidertrades.comExagen Inc (XGN) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Margin ...May 15, 2024 | finance.yahoo.comHealthcare Shares Soar Following Major Price Target IncreaseMay 15, 2024 | msn.comExagen’s Strong Q1 Earnings and Growth Potential Justify Buy RatingMay 14, 2024 | markets.businessinsider.comExagen First Quarter 2024 Earnings: Beats ExpectationsMay 14, 2024 | finance.yahoo.comExagen beats top-line and bottom-line estimates; raises FY24 outlookMay 13, 2024 | msn.com Get Exagen News Delivered to You Automatically Sign up to receive the latest news and ratings for XGN and its competitors with MarketBeat's FREE daily newsletter. Email Address XGN Media Mentions By Week XGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XGN News Sentiment▼0.000.60▲Average Medical News Sentiment XGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XGN Articles This Week▼01▲XGN Articles Average Week Get Exagen News Delivered to You Automatically Sign up to receive the latest news and ratings for XGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BDSX News SERA News QIPT News EUDA News PIII News TOI News BNR News ENZ News CCM News NIVF News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XGN) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exagen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XGN Stock Alerts